论文信息 - Treatment of artificially induced storage disease with lysosomotropic microparticles. - 字舞流文

Treatment of artificially induced storage disease with lysosomotropic microparticles.

I. Sjöholm | P. Edman

[1] D. Knook,et al. Isolated parenchymal, Kupffer and endothelial rat liver cells characterized by their lysosomal enzyme content. , 1980, Biochemical and biophysical research communications.

[2] I. Sjöholm,et al. Immobilization of proteins in microspheres of biodegradable polyacryldextran. , 1980, Journal of pharmaceutical sciences.

[3] I. Sjöholm,et al. Acrylic microspheres in vivo. I. Distribution and elimination of polyacrylamide microparticles after intravenous and intraperitoneal injection in mouse and rat. , 1979, The Journal of pharmacology and experimental therapeutics.

[4] H. J. Baker,et al. Enzyme replacement using liposome carriers in feline GM1 gangliosidosis fibroblasts , 1978, Nature.

[5] P. Couvreur,et al. Nanocapsules: A new type of lysosomotropic carrier , 1977, FEBS letters.

[6] B. E. Ryman,et al. The use of a liposomally entrapped enzyme in the treatment of an artificial storage condition. , 1976, Biochimica et biophysica acta.

[7] I. Sjöholm,et al. Incorporation of macromolecules in microparticles: preparation and characteristics. , 1976, Biochemistry.

[8] G. Gregoriadis. The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[9] P. Kramer,et al. Phagocytosis of microspheres containing an anticancer agent by tumor cells in vitro. , 1976, Life sciences.

[10] I. Sjöholm,et al. Use of macromolecules in microparticles , 1975, Nature.

[11] J. Porath,et al. [105] A bacterial dextranase , 1966 .